IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v14y2023i1d10.1038_s41467-023-39421-5.html
   My bibliography  Save this article

Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses

Author

Listed:
  • Fredrika Hellgren

    (Karolinska Institutet and Karolinska University Hospital
    Center of Molecular Medicine)

  • Alberto Cagigi

    (Karolinska Institutet and Karolinska University Hospital
    Center of Molecular Medicine
    Nykode Therapeutics)

  • Rodrigo Arcoverde Cerveira

    (Karolinska Institutet and Karolinska University Hospital
    Center of Molecular Medicine)

  • Sebastian Ols

    (Karolinska Institutet and Karolinska University Hospital
    Center of Molecular Medicine)

  • Theresa Kern

    (Karolinska Institutet and Karolinska University Hospital
    Center of Molecular Medicine)

  • Ang Lin

    (Karolinska Institutet and Karolinska University Hospital
    Center of Molecular Medicine
    China Pharmaceutical University)

  • Bengt Eriksson

    (Karolinska Institutet)

  • Michael G. Dodds

    (Certara USA, Inc)

  • Edith Jasny

    (CureVac SE)

  • Kim Schwendt

    (CureVac SE)

  • Conrad Freuling

    (Friedrich-Loeffler-Institut, Greifswald-Insel Riems)

  • Thomas Müller

    (Friedrich-Loeffler-Institut, Greifswald-Insel Riems)

  • Martin Corcoran

    (Karolinska Institutet)

  • Gunilla B. Karlsson Hedestam

    (Karolinska Institutet)

  • Benjamin Petsch

    (CureVac SE)

  • Karin Loré

    (Karolinska Institutet and Karolinska University Hospital
    Center of Molecular Medicine)

Abstract

Licensed rabies virus vaccines based on whole inactivated virus are effective in humans. However, there is a lack of detailed investigations of the elicited immune response, and whether responses can be improved using novel vaccine platforms. Here we show that two doses of a lipid nanoparticle-formulated unmodified mRNA vaccine encoding the rabies virus glycoprotein (RABV-G) induces higher levels of RABV-G specific plasmablasts and T cells in blood, and plasma cells in the bone marrow compared to two doses of Rabipur in non-human primates. The mRNA vaccine also generates higher RABV-G binding and neutralizing antibody titers than Rabipur, while the degree of somatic hypermutation and clonal diversity of the response are similar for the two vaccines. The higher overall antibody titers induced by the mRNA vaccine translates into improved cross-neutralization of related lyssavirus strains, suggesting that this platform has potential for the development of a broadly protective vaccine against these viruses.

Suggested Citation

  • Fredrika Hellgren & Alberto Cagigi & Rodrigo Arcoverde Cerveira & Sebastian Ols & Theresa Kern & Ang Lin & Bengt Eriksson & Michael G. Dodds & Edith Jasny & Kim Schwendt & Conrad Freuling & Thomas Mül, 2023. "Unmodified rabies mRNA vaccine elicits high cross-neutralizing antibody titers and diverse B cell memory responses," Nature Communications, Nature, vol. 14(1), pages 1-15, December.
    • Handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-39421-5
    DOI: 10.1038/s41467-023-39421-5
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-023-39421-5
    File Function: Abstract
    Download Restriction: no
    File URL: https://libkey.io/10.1038/s41467-023-39421-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Aisling Irwin, 2021. "What it will take to vaccinate the world against COVID-19," Nature, Nature, vol. 592(7853), pages 176-178, April.
    2. Martin M. Corcoran & Ganesh E. Phad & Néstor Vázquez Bernat & Christiane Stahl-Hennig & Noriyuki Sumida & Mats A.A. Persson & Marcel Martin & Gunilla B. Karlsson Hedestam, 2016. "Production of individualized V gene databases reveals high levels of immunoglobulin genetic diversity," Nature Communications, Nature, vol. 7(1), pages 1-14, December.
    3. Robert W. Aldridge & Alexei Yavlinsky & Vincent Nguyen & Max T. Eyre & Madhumita Shrotri & Annalan M. D. Navaratnam & Sarah Beale & Isobel Braithwaite & Thomas Byrne & Jana Kovar & Ellen Fragaszy & Wi, 2022. "SARS-CoV-2 antibodies and breakthrough infections in the Virus Watch cohort," Nature Communications, Nature, vol. 13(1), pages 1-8, December.
    4. Prabhu S. Arunachalam & Madeleine K. D. Scott & Thomas Hagan & Chunfeng Li & Yupeng Feng & Florian Wimmers & Lilit Grigoryan & Meera Trisal & Venkata Viswanadh Edara & Lilin Lai & Sarah Esther Chang &, 2021. "Systems vaccinology of the BNT162b2 mRNA vaccine in humans," Nature, Nature, vol. 596(7872), pages 410-416, August.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Eva M. Stevenson & Sandra Terry & Dennis Copertino & Louise Leyre & Ali Danesh & Jared Weiler & Adam R. Ward & Pragya Khadka & Evan McNeil & Kevin Bernard & Itzayana G. Miller & Grant B. Ellsworth & C, 2022. "SARS CoV-2 mRNA vaccination exposes latent HIV to Nef-specific CD8+ T-cells," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    2. Yi-Tui Chen, 2021. "The Effect of Vaccination Rates on the Infection of COVID-19 under the Vaccination Rate below the Herd Immunity Threshold," IJERPH, MDPI, vol. 18(14), pages 1-10, July.
    3. Kevin J. Kramer & Erin M. Wilfong & Kelsey Voss & Sierra M. Barone & Andrea R. Shiakolas & Nagarajan Raju & Caroline E. Roe & Naveenchandra Suryadevara & Lauren M. Walker & Steven C. Wall & Ariana Pau, 2022. "Single-cell profiling of the antigen-specific response to BNT162b2 SARS-CoV-2 RNA vaccine," Nature Communications, Nature, vol. 13(1), pages 1-20, December.
    4. Josephine Borghi & Garrett W. Brown, 2022. "Taking Systems Thinking to the Global Level: Using the WHO Building Blocks to Describe and Appraise the Global Health System in Relation to COVID‐19," Global Policy, London School of Economics and Political Science, vol. 13(2), pages 193-207, May.
    5. Griffin, Bethany & Conner, Mark & Norman, Paul, 2022. "Applying an extended protection motivation theory to predict Covid-19 vaccination intentions and uptake in 50–64 year olds in the UK," Social Science & Medicine, Elsevier, vol. 298(C).
    6. Tomohiro Takano & Takashi Sato & Ryutaro Kotaki & Saya Moriyama & Shuetsu Fukushi & Masahiro Shinoda & Kiyomi Kabasawa & Nagashige Shimada & Mio Kousaka & Yu Adachi & Taishi Onodera & Kazutaka Terahar, 2023. "Heterologous SARS-CoV-2 spike protein booster elicits durable and broad antibody responses against the receptor-binding domain," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    7. Andrew P. Hederman & Harini Natarajan & Leo Heyndrickx & Kevin K. Ariën & Joshua A. Wiener & Peter F. Wright & Evan M. Bloch & Aaron A. R. Tobian & Andrew D. Redd & Joel N. Blankson & Amihai Rottenstr, 2023. "SARS-CoV-2 vaccination elicits broad and potent antibody effector functions to variants of concern in vulnerable populations," Nature Communications, Nature, vol. 14(1), pages 1-11, December.
    8. Forman, Rebecca & Shah, Soleil & Jeurissen, Patrick & Jit, Mark & Mossialos, Elias, 2021. "COVID-19 vaccine challenges: What have we learned so far and what remains to be done?," Health Policy, Elsevier, vol. 125(5), pages 553-567.
    9. Emanuele Blasioli & Bahareh Mansouri & Srinivas Subramanya Tamvada & Elkafi Hassini, 2023. "Vaccine Allocation and Distribution: A Review with a Focus on Quantitative Methodologies and Application to Equity, Hesitancy, and COVID-19 Pandemic," SN Operations Research Forum, Springer, vol. 4(2), pages 1-32, June.
    10. Kremer, Michael & Więcek, Witold & Ahuja, Amrita & Simoes Gomes Junior, Alexandre & Snyder, Christopher & Tabarrok, Alex & Tan, Brandon, 2021. "Could Vaccine Dose Stretching Reduce COVID-19 Deaths?," CEPR Discussion Papers 16324, C.E.P.R. Discussion Papers.
    11. Remco Johan Leonard Dijk & Catherine Yuk-ping Lo, 2023. "The effect of Chinese vaccine diplomacy during COVID-19 in the Philippines and Vietnam: a multiple case study from a soft power perspective," Palgrave Communications, Palgrave Macmillan, vol. 10(1), pages 1-12, December.
    12. Chaim A. Schramm & Damee Moon & Lowrey Peyton & Noemia S. Lima & Christian Wake & Kristin L. Boswell & Amy R. Henry & Farida Laboune & David Ambrozak & Samuel W. Darko & I-Ting Teng & Kathryn E. Fould, 2023. "Interaction dynamics between innate and adaptive immune cells responding to SARS-CoV-2 vaccination in non-human primates," Nature Communications, Nature, vol. 14(1), pages 1-17, December.
    13. Eric Mokwaro Bosire, 2023. "Viewpoints in Global Value Chains: Evidence from Sub-Saharan Africa," International Journal of Economics and Financial Issues, Econjournals, vol. 13(1), pages 13-28, January.
    14. Mark Chernyshev & Mrunal Sakharkar & Ruth I. Connor & Haley L. Dugan & Daniel J. Sheward & C. G. Rappazzo & Aron Stålmarck & Mattias N. E. Forsell & Peter F. Wright & Martin Corcoran & Ben Murrell & L, 2023. "Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages," Nature Communications, Nature, vol. 14(1), pages 1-12, December.
    15. Cozzi, Guido & Galli, Silvia, 2022. "Covid-19 Vaccines, Innovation, and Intellectual Property Rights," GLO Discussion Paper Series 1095, Global Labor Organization (GLO).
    16. Wen Juan Tu & Michelle Melino & Jenny Dunn & Robert D. McCuaig & Helle Bielefeldt-Ohmann & Sofiya Tsimbalyuk & Jade K. Forwood & Taniya Ahuja & John Vandermeide & Xiao Tan & Minh Tran & Quan Nguyen & , 2023. "In vivo inhibition of nuclear ACE2 translocation protects against SARS-CoV-2 replication and lung damage through epigenetic imprinting," Nature Communications, Nature, vol. 14(1), pages 1-21, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-39421-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.